BioCryst Pharmaceuticals, Inc. today announced that Stuart Grant will join the company’s senior management team as Senior Vice President and Chief Financial Officer

Kimberly-Clark Corporation today announced that Ian C. Read, senior vice president of Pfizer Inc. and president of Pfizer’s worldwide pharmaceutical operations, has been elected to its board of directors, effective August 15.

Kendle , a leading, global full-service clinical research organization, today announced the appointment of Thomas B. Smith, MD, as Vice President, Medical Affairs. Dr. Smith will develop

July 25 : Cedara Software, a Merge Healthcare company , and a leading medical imaging software and services company, announced the release of the Cedara I-Response

TargeGen, Inc. has announced that the Company has successfully closed a $40M venture round of financing.

ImmuneRegen BioSciences, a wholly owned subsidiary of IR BioSciences Holdings, Inc.

Rigel Pharmaceuticals Inc. today announced that its partner Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has begun enrolling patients in a Phase

EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, announced that it has entered into a collaborative research agreement with the University of New

Senomyx, Inc. , a leading company using proprietary technologies to discover and develop novel flavor ingredients for the packaged food and beverage industry,

Sigma-Aldrich Corporation , a leading Life Science and High Technology company with 2006 revenues of $1.8 billion, and Sangamo BioSciences, Inc. ,